| Price | $2.16 |
| Year Range | $1.82 – $2.77 |
| Market Cap | $25M |
| PE Ratio | 207 |
| Industry | Drug Manufacturers |
What Is TherapeuticsMD’s AI Stock Analysis?
TherapeuticsMD’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks TherapeuticsMD’s momentum in near-real time.
TherapeuticsMD (TXMD) has an AltIndex AI Score of 42/100, currently a Hold signal. The AI Score distills TherapeuticsMD's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
TherapeuticsMD’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of TherapeuticsMD — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving TXMD’s AI Score?
Fundamentals
Revenue for the last quarter was $870,000. This is an increase of 20.03% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 8.72%, which may be a cause for concern. Net income for the last quarter was $160,000. This is an increase of 63.16% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 71.87%, which may be a cause for concern. Ebitda for the last quarter was $160,000. This is an increase of -246.43% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of -173.54%, suggesting positive year-over-year growth. The current P/E ratio is 207. This may be considered high, potentially indicating overvaluation and a bearish outlook.
See TherapeuticsMD’s earnings and insider transactions.
Technicals
Today's stock price is $2.16. This is an increase of 4.35% compared to a month ago, indicating a positive short-term trend. Compared to a year ago, there is an increase of 100.00%, suggesting a positive long-term trend. The trend is bearish. The current SMA10 is $2.16, which is lower than the previous SMA10 of $2.16. This suggests a potential downward trend in price movement. The RSI is 50, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
The business outlook among employees at TherapeuticsMD is low (an estimate of only 33% of employees have a positive outlook), a concerning sign. TherapeuticsMD has an estimate of 8,000 visitors to their webpage. The number of visitors is up by 700% in the last couple of months, a bullish trend as this can indicate can increase in customers.
Explore TherapeuticsMD’s job postings, web traffic and app downloads.
Sentiment & social
TherapeuticsMD has 620 followers on their Twitter page. The number of followers is down by -1% in the last couple of months, indicating a loss in interest in the company.
Track TherapeuticsMD’s market sentiment.
Frequently Asked Questions: TherapeuticsMD AI Stock Analysis
TherapeuticsMD's AltIndex AI Score is 42/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates TherapeuticsMD a Hold (42/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of TherapeuticsMD — company overview, fundamentals, technicals and alternative data, with a recommendation. See the TXMD AI Score or sign up to read the full thesis.
